DIN 02254506 — ALDURAZYME 0.58 MG
ALDURAZYME is a solution of Laronidase marketed by SANOFI-AVENTIS CANADA INC. The full Laronidase monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02254506
- Brand name
- ALDURAZYME
- Active ingredient
- Laronidase
- Strength
- 0.58 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Enzyme replacement therapy (recombinant human alpha-L-iduronidase)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.